Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry

Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry

Détails bibliographiques
Publié dans:International journal of cancer 148(2021)6, S. 1478-1488
Auteurs principaux: Al-Batran, Salah-Eddin (Auteur), Hofheinz, Ralf-Dieter (Auteur), Bildat, Stephan (Auteur)
Format: Article
Langue:English
Publié: 2021
Sujets:
Publikation <Klinikum Herford>
Onkologie <Klinik, Klinikum Herford>
Klinikum Herford
Zeitschriftenartikel
Accès en ligne:https://doi.org/10.1002/ijc.33336
Documents similaires:In: International journal of cancer
Description
Description:Zweigstelle: Medizinische Bibliothek
Exemplar/Standort: Zs Open Access
Exemplar/Standort: Zs Kopie (MedBib)
Exemplar/Standort: Medizinische Bibliothek
DOI:10.1002/ijc.33336
Cote:Zs Open Access

Documents similaires